首页> 美国卫生研究院文献>Acta Crystallographica Section F: Structural Biology and Crystallization Communications >Overexpression purification and crystallographic analysis of a unique adenosine kinase from Mycobacterium tuberculosis
【2h】

Overexpression purification and crystallographic analysis of a unique adenosine kinase from Mycobacterium tuberculosis

机译:结核分枝杆菌独特腺苷激酶的过表达纯化和晶体学分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Adenosine kinase from Mycobacterium tuberculosis is the only prokaryotic adenosine kinase that has been isolated and characterized. The enzyme catalyzes the phosphorylation of adenosine to adenosine monophosphate and is involved in the activation of 2-methyladenosine, a compound that has demonstrated selective activity against M. tuberculosis. The mechanism of action of 2-methyladenosine is likely to be different from those of current tuberculosis treatments and this compound (or other adenosine analogs) may prove to be a novel therapeutic intervention for this disease. The M. tuberculosis adenosine kinase was overexpressed in Escherichia coli and the enzyme was purified with activity comparable to that reported previously. The protein was crystallized in the presence of adenosine using the vapour-diffusion method. The crystals diffracted X-rays to high resolution and a complete data set was collected to 2.2 Å using synchrotron radiation. The crystal belonged to space group P3121, with unit-cell parameters a = 70.2, c = 111.6 Å, and contained a single protein molecule in the asymmetric unit. An initial structural model of the protein was obtained by the molecular-replacement method, which revealed a dimeric structure. The monomers of the dimer were related by twofold crystallographic symmetry. An understanding of how the M. tuberculosis adenosine kinase differs from the human homolog should aid in the design of more potent and selective antimycobacterial agents that are selectively activated by this enzyme.
机译:来自结核分枝杆菌的腺苷激酶是唯一已分离和鉴定的原核腺苷激酶。该酶催化腺苷磷酸化为单磷酸腺苷,并参与了2-甲基腺苷的活化,该化合物已显示出对结核分枝杆菌的选择性活性。 2-甲基腺苷的作用机制可能与当前的结核病治疗不同,该化合物(或其他腺苷类似物)可能被证明是对该疾病的一种新型治疗手段。结核分枝杆菌腺苷激酶在大肠杆菌中过表达,并且该酶的纯化活性与以前报道的相当。使用蒸气扩散法在腺苷存在下使蛋白质结晶。晶体将X射线衍射到高分辨率,并使用同步加速器辐射将完整的数据集收集到2.2Å。该晶体属于空间群P3121,晶胞参数a = 70.2,c = 111.6Å,并且在不对称单元中包含单个蛋白质分子。通过分子置换方法获得了蛋白质的初始结构模型,其揭示了二聚体结构。二聚体的单体通过双重晶体对称性关联。对结核分枝杆菌腺苷激酶与人类同源物有何不同的理解应有助于设计更有效和选择性更高的抗分枝杆菌药物,这些药物可以选择性地激活该酶。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号